【格林基金郑中华：医药行业中长期机会显著大于风险】金十数据5月29日讯，5月29日晚间，格林基金总经理助理、权益投资总监、基金经理郑中华表示，医药行业近期表现显著超越市场平均涨幅，特别是创新药的一些细分行业和个股，出现了显著上涨。从中长期来看，医药行业的机会显著大于风险。郑中华表示，一般来说，如果某个行业存在中长期的上行机会，成长性和创新性较高的细分行业存在超额涨幅。因此，创新药、医疗器械等高成长赛道将引领医药行业反弹，而中药、药店、医药流通等板块则需自下而上挖掘个股机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.